US FDA Allows Orphan Drug Designation To CBL-514 For Dercum's Treatment

Caliway Biopharmaceuticals declared that the US Food and Medication Organization (FDA) permitted Orphan Drug Designation (ODD) to CBL-514 for Dercum's illness treatment. CBL-514 is a lipolysis injection that can diminish nearby subcutaneous fat...

Sandoz Acquires Cimerli business From Coherus BioSciences

Sandoz, the leader in conventional and biosimilar drugs, has acquired the US biosimilar Cimerli (ranibizumab-eqrn) from Coherus BioSciences, Inc., before expected timetables. The procurement expands on the main Sandoz ophthalmic stage in the US...

Leading Firm Cadila Pharmaceuticals Launches Vaccine For Seasonal flu

Cadila Pharmaceuticals said it has introduced an immunization to prevent flu, a repetitive and far and wide viral infection. The medication firm has presented quadrivalent Cadiflu Tetra immunization, endorsed by the DCGI (Drugs Controller General...

Ayush-ICMR Health Research Center Launched at AIIMS

Union Minister of Health and Family Welfare Dr Mansukh Mandaviya launched the Ayush-ICMR Advanced Centre for Integrated Health Research in AIIMS and announced other mega joint initiatives between the Health Ministry and the Ministry of Ayush.

Rare Disease Action Plan 2024 Launched, NIHCR Welcomes

The UK Government's Rare Disease Action Plan 2024 has been published, detailing what the NIHR, DHSC and others have done over the past year to better meet the needs of patients with rare diseases.

Indira IVF and BD SurePath Partner for Cervical Cancer Screening in India

In a major move to improve the accuracy and accessibility of breast cancer screening in India, Indira IVF has partnered with BD SurePath.

© 2024 India Pharma Outlook. All Rights Reserved.